A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.
The World Health Organization recommends at least 3 annual antibiotic mass drug administrations (MDA) where the prevalence of trachoma is > 10% in children ages 1-9 years, with coverage at least at 80%. However, the additional value of higher coverage targeted at children with multiple rounds is...
Saved in:
Main Authors: | Sheila K West (Author), Robin Bailey (Author), Beatriz Munoz (Author), Tansy Edwards (Author), Harran Mkocha (Author), Charlotte Gaydos (Author), Thomas Lietman (Author), Travis Porco (Author), David Mabey (Author), Thomas C Quinn (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mass treatment with azithromycin for trachoma control: participation clusters in households.
by: Elizabeth N Ssemanda, et al.
Published: (2010) -
Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
by: Fengchen Liu, et al.
Published: (2013) -
Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds.
by: Elizabeth N Ssemanda, et al.
Published: (2012) -
Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia.
by: Sarah E Burr, et al.
Published: (2013) -
Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
by: Fengchen Liu, et al.
Published: (2013)